GlassScriptPhysician profile
Mark Skousen
NPI 1013529155
$1,480.40
in general payments reported to CMS, 2019-2025
13 companies · $829 in 2025
The $829 reported for 2025 was more than what 77% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $151 · 2022: $134 · 2023: $165 · 2024: $202 · 2025: $829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,035 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,035.00 |
| Education | $160.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $410.90 | 2021-2025 | Invega Sustenna, Invega Trinza, Invega |
| Teva Pharmaceuticals USA, INC. | $355.95 | 2022-2025 | Austedo Xr, Uzedy |
| Otsuka America Pharmaceutical, INC. | $154.84 | 2023-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Neurocrine Biosciences, INC. | $129.83 | 2023-2025 | Ingrezza |
| E.R. Squibb & Sons, L.L.C. | $83.40 | 2025 | Cobenfy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $77.55 | 2021-2023 | |
| Alkermes, INC. | $76.22 | 2023-2025 | Lybalvi, Aristada |
| Vanda Pharmaceuticals INC. | $68.59 | 2025 | Fanapt |
| Glaxosmithkline, LLC. | $38.70 | 2025 | Trelegy Ellipta |
| Supernus Pharmaceuticals, INC. | $28.58 | 2025 | Qelbree |
| Xeris Pharmaceuticals, INC. | $22.02 | 2024 | Gvoke Hypopen |
| Biohaven Pharmaceutical Holding Company LTD. | $18.30 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.52 | 2024 | Airsupra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Skousen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.